Red Light Holland Corp. SEDAR Filings

News 2026-06-08

Red Light Holland's Filament Health Signs Agreement to Supply PEX010 for Study at GHU Paris Psychiatrie & Neurosciences

News release - English.pdf

News 2026-06-04

Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers

News release - English.pdf

News 2026-05-25

Open PDF

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

News release - English.pdf

News 2026-05-14

Open PDF

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research

News release - English.pdf

Transactions 2026-05-12 M&A

Open PDF

Red Light Holland Corp. Completes Acquisition of Filament Health Corp. and Announces Intention to Rebrand

Material change report - English.pdf

News 2026-05-08

Open PDF

Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property

News release - English.pdf

News 2026-05-07

Open PDF

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions

News release - English.pdf

Results 2026-05-04

Audited annual financial statements – English.pdf

News 2026-05-04

Open PDF

Red Light Holland Announces Intention to Rebrand

News release - English.pdf

Ownership 2026-05-01

Early warning report.pdf

Transactions 2026-04-30 M&A

Open PDF

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

News release - English.pdf

Transactions 2026-04-29 M&A

Open PDF

Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement

News release - English.pdf

Transactions 2026-04-27 M&A

Open PDF

Red Light Holland Announces Filament Health Shareholder Approval of Acquisition

News release - English.pdf

News 2026-04-24

Open PDF

Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments

News release - English.pdf

News 2026-04-20

Open PDF

Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate

News release - English.pdf

News 2026-04-07

Open PDF

Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments

News release - English.pdf

News 2026-04-01

Open PDF

Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network

News release - English.pdf

Transactions 2026-03-23 M&A

Open PDF

Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement

News release - English.pdf

News 2026-03-20